• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

工程化心脏组织:一种体外研究心脏缺血变化的新工具。

Engineered heart tissue: a novel tool to study the ischemic changes of the heart in vitro.

机构信息

Department of Cardiovascular Control, Kochi Medical School, Nankoku, Japan.

出版信息

PLoS One. 2010 Feb 17;5(2):e9275. doi: 10.1371/journal.pone.0009275.

DOI:10.1371/journal.pone.0009275
PMID:20174664
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2822866/
Abstract

BACKGROUND

Understanding the basic mechanisms and prevention of any disease pattern lies mainly on development of a successful experimental model. Recently, engineered heart tissue (EHT) has been demonstrated to be a useful tool in experimental transplantation. Here, we demonstrate a novel function for the spontaneously contracting EHT as an experimental model in studying the acute ischemia-induced changes in vitro.

METHODOLOGY/PRINCIPAL FINDINGS: EHT was constructed by mixing cardiomyocytes isolated from the neonatal rats and cultured in a ring-shaped scaffold for five days. This was followed by mechanical stretching of the EHT for another one week under incubation. Fully developed EHT was subjected to hypoxia with 1% O(2) for 6 hours after treating them with cell protective agents such as cyclosporine A (CsA) and acetylcholine (ACh). During culture, EHT started to show spontaneous contractions that became more synchronous following mechanical stretching. This was confirmed by the increased expression of gap junctional protein connexin 43 and improved action potential recordings using an optical mapping system after mechanical stretching. When subjected to hypoxia, EHT demonstrated conduction defects, dephosphorylation of connexin-43, and down-regulation of cell survival proteins identical to the adult heart. These effects were inhibited by treating the EHT with cell protective agents.

CONCLUSIONS/SIGNIFICANCE: Under hypoxic conditions, the EHT responds similarly to the adult myocardium, thus making EHT a promising material for the study of cardiac functions in vitro.

摘要

背景

了解任何疾病模式的基本机制和预防主要依赖于成功的实验模型的开发。最近,工程心脏组织 (EHT) 已被证明是实验移植的有用工具。在这里,我们展示了自发收缩的 EHT 在体外研究急性缺血诱导变化的新功能。

方法/主要发现:EHT 通过混合从新生大鼠中分离的心肌细胞并在环形支架中培养五天来构建。然后在孵育下对 EHT 进行另一个为期一周的机械拉伸。在用细胞保护剂如环孢素 A (CsA) 和乙酰胆碱 (ACh) 处理后,将完全发育的 EHT 置于 1% O(2) 下缺氧 6 小时。在培养过程中,EHT 开始显示自发性收缩,机械拉伸后收缩变得更加同步。这通过机械拉伸后间隙连接蛋白 connexin 43 的表达增加和使用光学映射系统记录的动作电位得到证实。在缺氧条件下,EHT 表现出与成年心脏相同的传导缺陷、连接蛋白-43 的去磷酸化和细胞存活蛋白的下调。这些作用可以通过用细胞保护剂处理 EHT 来抑制。

结论/意义:在缺氧条件下,EHT 对成年心肌的反应相似,因此 EHT 是研究体外心脏功能的有前途的材料。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff0b/2822866/dfae0662b800/pone.0009275.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff0b/2822866/b353f8f280cd/pone.0009275.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff0b/2822866/1a83e4c3c3ab/pone.0009275.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff0b/2822866/6163206cca71/pone.0009275.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff0b/2822866/dfae0662b800/pone.0009275.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff0b/2822866/b353f8f280cd/pone.0009275.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff0b/2822866/1a83e4c3c3ab/pone.0009275.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff0b/2822866/6163206cca71/pone.0009275.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff0b/2822866/dfae0662b800/pone.0009275.g004.jpg

相似文献

1
Engineered heart tissue: a novel tool to study the ischemic changes of the heart in vitro.工程化心脏组织:一种体外研究心脏缺血变化的新工具。
PLoS One. 2010 Feb 17;5(2):e9275. doi: 10.1371/journal.pone.0009275.
2
Functional improvement and maturation of rat and human engineered heart tissue by chronic electrical stimulation.通过慢性电刺激实现大鼠和人类工程心脏组织的功能改善与成熟
J Mol Cell Cardiol. 2014 Sep;74:151-61. doi: 10.1016/j.yjmcc.2014.05.009. Epub 2014 May 19.
3
Terminal differentiation, advanced organotypic maturation, and modeling of hypertrophic growth in engineered heart tissue.工程化心脏组织中的终末分化、高级器官型成熟和肥厚生长建模。
Circ Res. 2011 Oct 28;109(10):1105-14. doi: 10.1161/CIRCRESAHA.111.251843. Epub 2011 Sep 15.
4
Transplantation of engineered heart tissue as a biological cardiac assist device for treatment of dilated cardiomyopathy.工程化心脏组织移植作为生物心脏辅助装置治疗扩张型心肌病。
Eur J Heart Fail. 2013 Jan;15(1):23-35. doi: 10.1093/eurjhf/hfs200.
5
Tissue engineering of a differentiated cardiac muscle construct.分化型心肌构建体的组织工程
Circ Res. 2002 Feb 8;90(2):223-30. doi: 10.1161/hh0202.103644.
6
[Experimental study of tissue-engineered heart tissue using type I collagen as scaffold].以I型胶原为支架构建组织工程心脏组织的实验研究
Zhonghua Yi Xue Za Zhi. 2004 May 2;84(9):766-70.
7
Optimizing engineered heart tissue for therapeutic applications as surrogate heart muscle.优化工程化心脏组织以作为替代心肌用于治疗应用。
Circulation. 2006 Jul 4;114(1 Suppl):I72-8. doi: 10.1161/CIRCULATIONAHA.105.001560.
8
Rat atrial engineered heart tissue: a new in vitro model to study atrial biology.大鼠心房工程化心脏组织:研究心房生物学的新体外模型。
Basic Res Cardiol. 2018 Sep 3;113(5):41. doi: 10.1007/s00395-018-0701-2.
9
Contractile and electrophysiologic characterization of optimized self-organizing engineered heart tissue.优化的自组织工程心脏组织的收缩和电生理特性。
Ann Thorac Surg. 2012 Oct;94(4):1241-8; discussion 1249. doi: 10.1016/j.athoracsur.2012.04.098. Epub 2012 Jul 12.
10
Fabrication of engineered heart tissue grafts from alginate/collagen barium composite microbeads.从海藻酸钙/胶原钡复合微球制备工程心脏组织移植物。
Biomed Mater. 2011 Aug;6(4):045002. doi: 10.1088/1748-6041/6/4/045002. Epub 2011 May 26.

引用本文的文献

1
Cardiac organ chip: advances in construction and application.心脏器官芯片:构建与应用进展
Biomater Transl. 2024 Nov 15;5(4):411-424. doi: 10.12336/biomatertransl.2024.04.006. eCollection 2024.
2
Multicellular 3D models to study myocardial ischemia-reperfusion injury.用于研究心肌缺血再灌注损伤的多细胞3D模型。
Front Cell Dev Biol. 2024 Nov 15;12:1494911. doi: 10.3389/fcell.2024.1494911. eCollection 2024.
3
Modelling Diabetic Cardiomyopathy: Using Human Stem Cell-Derived Cardiomyocytes to Complement Animal Models.

本文引用的文献

1
Cardiac stem cell genetic engineering using the alphaMHC promoter.使用 alphaMHC 启动子的心脏干细胞基因工程。
Regen Med. 2009 Nov;4(6):823-33. doi: 10.2217/rme.09.51.
2
Interrogating functional integration between injected pluripotent stem cell-derived cells and surrogate cardiac tissue.探究注射的多能干细胞源性细胞与替代心脏组织之间的功能整合。
Proc Natl Acad Sci U S A. 2010 Feb 23;107(8):3329-34. doi: 10.1073/pnas.0905729106. Epub 2009 Oct 21.
3
Physiological function and transplantation of scaffold-free and vascularized human cardiac muscle tissue.
糖尿病心肌病建模:利用人干细胞衍生的心肌细胞补充动物模型
Metabolites. 2022 Sep 3;12(9):832. doi: 10.3390/metabo12090832.
4
Myocardial infarction from a tissue engineering and regenerative medicine point of view: A comprehensive review on models and treatments.从组织工程与再生医学角度看心肌梗死:关于模型与治疗的全面综述
Biophys Rev (Melville). 2022 Sep;3(3):031305. doi: 10.1063/5.0093399. Epub 2022 Aug 30.
5
Cardiac ischemia on-a-chip to investigate cellular and molecular response of myocardial tissue under hypoxia.芯片上的心脏缺血研究缺氧条件下心肌组织的细胞和分子反应。
Biomaterials. 2022 Feb;281:121336. doi: 10.1016/j.biomaterials.2021.121336. Epub 2021 Dec 30.
6
Considerations to Model Heart Disease in Women with Preeclampsia and Cardiovascular Disease.考虑建立先兆子痫和心血管疾病女性心脏病模型。
Cells. 2021 Apr 14;10(4):899. doi: 10.3390/cells10040899.
7
Disease-inspired tissue engineering: Investigation of cardiovascular pathologies.疾病启发的组织工程学:心血管病变的研究。
ACS Biomater Sci Eng. 2020 May 11;6(5):2518-2532. doi: 10.1021/acsbiomaterials.9b01067. Epub 2019 Oct 29.
8
Effects of the Delta Opioid Receptor Agonist DADLE in a Novel Hypoxia-Reoxygenation Model on Human and Rat-Engineered Heart Tissue: A Pilot Study.新型缺氧复氧模型中 Delta 阿片受体激动剂 DADLE 对人心肌和大鼠工程化心肌组织的影响:一项初步研究。
Biomolecules. 2020 Sep 11;10(9):1309. doi: 10.3390/biom10091309.
9
Towards chamber specific heart-on-a-chip for drug testing applications.针对药物测试应用的特定心室心脏芯片。
Adv Drug Deliv Rev. 2020;165-166:60-76. doi: 10.1016/j.addr.2019.12.002. Epub 2020 Jan 7.
10
Fibroblasts Slow Conduction Velocity in a Reconstituted Tissue Model of Fibrotic Cardiomyopathy.在纤维化心肌病的重组组织模型中,成纤维细胞减缓传导速度。
ACS Biomater Sci Eng. 2017 Nov 13;3(11):3022-3028. doi: 10.1021/acsbiomaterials.6b00576. Epub 2016 Oct 18.
无支架血管化人心脏肌肉组织的生理功能与移植
Proc Natl Acad Sci U S A. 2009 Sep 29;106(39):16568-73. doi: 10.1073/pnas.0908381106. Epub 2009 Sep 17.
4
Cell sheet-based myocardial tissue engineering: new hope for damaged heart rescue.基于细胞片的心肌组织工程:拯救受损心脏的新希望。
Curr Pharm Des. 2009;15(24):2807-14. doi: 10.2174/138161209788923822.
5
Transplantation of a tissue-engineered human vascularized cardiac muscle.组织工程化人血管化心肌移植。
Tissue Eng Part A. 2010 Jan;16(1):115-25. doi: 10.1089/ten.TEA.2009.0130.
6
Implantation of engineered tissue in the rat heart.工程组织在大鼠心脏中的植入。
J Vis Exp. 2009 Jun 24(28):1139. doi: 10.3791/1139.
7
Vascularization--the conduit to viable engineered tissues.血管化--可存活工程组织的通道。
Tissue Eng Part B Rev. 2009 Jun;15(2):159-69. doi: 10.1089/ten.teb.2008.0193.
8
Vagal nerve stimulation prevents reperfusion injury through inhibition of opening of mitochondrial permeability transition pore independent of the bradycardiac effect.迷走神经刺激通过抑制线粒体通透性转换孔的开放来预防再灌注损伤,这一作用独立于心动过缓效应。
J Thorac Cardiovasc Surg. 2009 Jan;137(1):223-31. doi: 10.1016/j.jtcvs.2008.08.020.
9
Tissue-engineered heart valve prostheses: 'state of the heart'.
Regen Med. 2008 May;3(3):399-419. doi: 10.2217/17460751.3.3.399.
10
Novel bisindolylmaleimide derivative inhibits mitochondrial permeability transition pore and protects the heart from reperfusion injury.新型双吲哚马来酰亚胺衍生物抑制线粒体通透性转换孔并保护心脏免受再灌注损伤。
Can J Physiol Pharmacol. 2007 Oct;85(10):979-85. doi: 10.1139/y07-071.